[Skip to Navigation]
Sign In

September 2021 - January 1920

Decade

Year

Issue

February 2021, Vol 157, No. 2, Pages 143-240

Editorial

Challenges and Controversy in Determining UV Exposure as a Risk Factor for Cutaneous Melanoma in Skin of Color

Abstract Full Text
JAMA Dermatol. 2021;157(2):151-153. doi:10.1001/jamadermatol.2020.4615

Reconsidering Named Honorifics in Medicine—the Troubling Legacy of Dermatologist Albert Kligman

Abstract Full Text
JAMA Dermatol. 2021;157(2):153-155. doi:10.1001/jamadermatol.2020.4570

Advocating for Black Lives—A Call to Dermatologists to Dismantle Institutionalized Racism and Address Racial Health Inequities

Abstract Full Text
JAMA Dermatol. 2021;157(2):155-156. doi:10.1001/jamadermatol.2020.4392
Original Investigation

Association of a Proposed New Staging System for Folliculotropic Mycosis Fungoides With Prognostic Variables in a US Cohort

Abstract Full Text
JAMA Dermatol. 2021;157(2):157-165. doi:10.1001/jamadermatol.2020.4372

This cohort study assesses predictive factors associated with survival and evaluates the effectiveness of the newly proposed staging system for estimating overall and disease-specific survival in a US cohort of patients with folliculotropic mycosis fungoides.

Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma

Abstract Full Text
JAMA Dermatol. 2021;157(2):166-173. doi:10.1001/jamadermatol.2020.5032

This cohort study examines the association of histologically confirmed regression with survival in patients with primary cutaneous melanoma.

Rates of Vascular Occlusion Associated With Using Needles vs Cannulas for Filler Injection

Abstract Full Text
JAMA Dermatol. 2021;157(2):174-180. doi:10.1001/jamadermatol.2020.5102

This cohort study explores whether filler-associated vascular occlusion events of the face occur more often with injections performed with needles than with microcannulas.

Insurance Acceptance, Appointment Wait Time, and Dermatologist Access Across Practice Types in the US

Abstract Full Text
JAMA Dermatol. 2021;157(2):181-188. doi:10.1001/jamadermatol.2020.5173

This cross-sectional study examines appointment success and wait times for patients with various insurance types at clinics with and without private equity ownership.

Dermoscopy Proficiency Expectations for US Dermatology Resident Physicians: Results of a Modified Delphi Survey of Pigmented Lesion Experts

Abstract Full Text
JAMA Dermatol. 2021;157(2):189-197. doi:10.1001/jamadermatol.2020.5213

This survery study examines consensus-based learning constructs that represent an appropriate foundational proficiency in dermoscopic image interpretation for dermatology resident physicians.

Brief Report

Psoriasis Flares Following Systemic Glucocorticoid Exposure in Patients With a History of Psoriasis

Abstract Full Text
has active quiz
JAMA Dermatol. 2021;157(2):198-201. doi:10.1001/jamadermatol.2020.4219

This cohort study examines the rates and types of psoriasis flares during or within 3 months after concluding systemic corticosteroid administration in adult patients with a known history of psoriasis.

Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic

Abstract Full Text
free access has active quiz
JAMA Dermatol. 2021;157(2):202-206. doi:10.1001/jamadermatol.2020.4324

This retrospective case series describes a systematic assessment of 40 patients with chilblain-like lesions durring the coronavirus 2019 pandemic and examines the association of these lesions with a viral-induced type I interferonopathy.

Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic

Abstract Full Text
free access has active quiz
JAMA Dermatol. 2021;157(2):207-212. doi:10.1001/jamadermatol.2020.4779

This case series describes the mucocutaneous findings seen in children with multisystem inflammatory syndrome in children during the height of the coronavirus disease 2019 (COVID-19) pandemic in New York City in 2020.

Review

UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color: A Systematic Review

Abstract Full Text
has audio
JAMA Dermatol. 2021;157(2):213-219. doi:10.1001/jamadermatol.2020.4616

This systematic review critically assesses and synthesizes the published data regarding the association between UV exposure and the risk of cutaneous melanoma in skin of color.

Images in Dermatology

Neonatal Pemphigus Vulgaris

Abstract Full Text
JAMA Dermatol. 2021;157(2):220. doi:10.1001/jamadermatol.2020.3990

This case report describes superficial annular erosions with central granulation tissue and desquamating borders on the occipital scalp, postauricular region, nape, and right calf.

Linear Immunoglobulin—A Bullous Dermatosis

Abstract Full Text
JAMA Dermatol. 2021;157(2):221. doi:10.1001/jamadermatol.2020.4006

This case report describes expanding concentric vesicles and bullae on the trunk and extremities.

JAMA Dermatology Clinicopathological Challenge

Leonine Facies and Madarosis in a Man With Shortness of Breath

Abstract Full Text
has active quiz
JAMA Dermatol. 2021;157(2):222-223. doi:10.1001/jamadermatol.2020.5090

A man in his 60s presented for evaluation of lesions on the face, chest, back, and arms that were gradually increasing in size and number. What is your diagnosis?

Annular Plaques in a Woman Receiving Systemic Immunotherapy

Abstract Full Text
has active quiz
JAMA Dermatol. 2021;157(2):224-225. doi:10.1001/jamadermatol.2020.4810

A woman in her 70s with recurrent primary peritoneal carcinoma receiving pembrolizumab and ipilimumab presents with pruritic rash. What is your diagnosis?

Research Letter

Burden of Ocular Comorbidities in Patients With Hidradenitis Suppurativa

Abstract Full Text
JAMA Dermatol. 2021;157(2):226-227. doi:10.1001/jamadermatol.2020.5087

This case-control study examines the burden of ocular comorbidities in patients with hidradenitis suppurativa.

Pregnancy in Hidradenitis Suppurativa—Patient Perspectives and Practice Gaps

Abstract Full Text
JAMA Dermatol. 2021;157(2):227-230. doi:10.1001/jamadermatol.2020.5162

This survey study reports on patients’ concerns about the implications of hidradenitis suppurativa for sexual and reproductive health, heritability of the condition, and pregnancy and childbirth as well as the inadequate information and support from clinicians.

Evaluation of Etanercept for Treatment of Reactive Infectious Mucocutaneous Eruption

Abstract Full Text
JAMA Dermatol. 2021;157(2):230-232. doi:10.1001/jamadermatol.2020.5166

This cohort study evaluates the association of etanercept treatment with outcomes of reactive infectious mucocutaneous eruption in hospitalized children and adolescents.

Mucocutaneous Adverse Events Associated With Oral Sirolimus for the Treatment of Vascular Anomalies

Abstract Full Text
JAMA Dermatol. 2021;157(2):233-235. doi:10.1001/jamadermatol.2020.5180

This case series examines the clinical spectrum and frequency of mucocutaneous adverse events related to oral sirolimus in populations with vascular anomalies.

Observation

Treatment of Xanthoma Disseminatum With Narrowband UV-B Phototherapy

Abstract Full Text
JAMA Dermatol. 2021;157(2):235-237. doi:10.1001/jamadermatol.2020.4092

This case report describes xanthoma disseminatum that was successfully treated with narrowband ultraviolet B phototherapy.

Association of Programmed Cell Death 1 Inhibitor With Circumorificial Plasmacytosis

Abstract Full Text
JAMA Dermatol. 2021;157(2):237-238. doi:10.1001/jamadermatol.2020.4273

This case report describes diffusively enlarged, erythematous, and cobblestoned maxillary and mandibular buccal gingivae.

Comment & Response

Emerging Evidence of the Direct Association Between COVID-19 and Chilblains

Abstract Full Text
free access
JAMA Dermatol. 2021;157(2):238-239. doi:10.1001/jamadermatol.2020.4937

Emerging Evidence of the Direct Association Between COVID-19 And Chilblains—Reply

Abstract Full Text
free access
JAMA Dermatol. 2021;157(2):239-240. doi:10.1001/jamadermatol.2020.4655
Correction

Error in Author Name

Abstract Full Text
free access
JAMA Dermatol. 2021;157(2):240. doi:10.1001/jamadermatol.2021.0069
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2021;157(2):143. doi:10.1001/jamadermatol.2020.3860
×